Ticker
GRCECompany Name
GRACE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -20.63% | $ -13.11M | $ 63.55M |
3/31/2025 | -22.38% | $ -14.9M | $ 66.61M |
12/31/2024 | -26.96% | $ -14.06M | $ 52.14M |
9/30/2024 | -21.09% | $ -11.84M | $ 56.13M |
6/30/2024 | -16.17% | $ -9.6M | $ 59.36M |
3/31/2024 | -19.83% | $ -12.24M | $ 61.74M |
12/31/2023 | -20.82% | $ -13.47M | $ 64.7M |
9/30/2023 | -22.91% | $ -15.3M | $ 66.79M |
6/30/2023 | -26.11% | $ -16.74M | $ 64.09M |
3/31/2023 | -23.28% | $ -15.93M | $ 68.44M |
FCF / Inv. Capital
(=) CROIC
CROIC for GRACE THERAPEUTICS INC is calculated as follows: FCF [ $ -18.43M ] / Inv. Capital [ $ 8.99M ]
(=) CROIC [ -204.98% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.3% |
average | 2.82% |
median | 5% |
std | 15.01% |